The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.
Open accessAbstract
Adenosine potentiates mast cell activation, but the receptor type and molecular mechanisms involved have not been defined. We, therefore, investigated the effects of adenosine on the human mast cell line HMC-1. Both the A2a selective agonist CGS21680 and the A2a/A2b nonselective agonist 5'-N-ethylcarboxamidoadenosine (NECA) increased cAMP, but NECA was fourfold more efficacious and had a Hill coefficient of 0.55, suggesting the presence of both A2a and A2b receptors. NECA 10 microM evoked IL-8 release from HMC-1, but CGS21680 10 microM had no effect. In separate studies we found that enprofylline, an antiasthmatic previously thought to lack adenosine antagonistic properties, is as effective as theophylline as an antagonist of A2b receptors at concentrations achieved clinically. Both theophylline and enprofylline 300 micro completely blocked the release of IL-8 by NECA. NECA, but not CGS21680, increases inositol phosphate formation and intracellular calcium mobilization through a cholera and pertussis toxin-insensitive mechanism. In conclusion, both A2a and A2b receptors are present in HMC-1 cells and are coupled to adenylate cyclase. In addition, A2b receptors are coupled to phospholipase C and evoke IL-8 release. This effect is blocked by theophylline and enprofylline, raising the possibility that this mechanism contributes to their antiasthmatic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
A Protein Binding Assay for Adenosine 3′:5′-Cyclic Monophosphate
Gilman, A. G. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.67.1.305 · Cited by 3,249
Two types of human mast cells that have distinct neutral protease compositions.
Irani, A. A., Schechter, N. M., Craig, S. S., DeBlois, G., & Schwartz, L. B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4464 · Cited by 1,005
Establishment of an immature mast cell line from a patient with mast cell leukemia
Butterfield, J. H., Weiler, D., Dewald, G., & Gleich, G. J. (1988) · Leukemia Research · doi:10.1016/0145-2126(88)90050-1 · Cited by 737
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 658
Ramkumar, V., Stiles, G. L., Beaven, M. A., & Ali, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85277-8 · Cited by 448
Molecular cloning and characterization of the human A3 adenosine receptor.
Salvatore, C. A., Jacobson, M. A., Taylor, H. E., Linden, J., & Johnson, R. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10365 · Cited by 424
Potentiation of Mast Cell Mediator Release by Adenosine
Marquardt, D. L., Parker, C. W., & Sullivan, T. J. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.3.871 · Cited by 267
Phenotypic Characterization of the Human Mast‐Cell Line HMC‐1
NILSSON, G., BLOM, T., KUSCHE‐GULLBERG, M., KJELLEN, L., BUTTERFIELD, J. H., SUNDSTRÖM, C., NILSSON, K., & HELLMAN, L. (1994) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1994.tb03404.x · Cited by 258
Björck, T., Gustafsson, L. E., & Dahlén, S.-E. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.5.1087 · Cited by 226
Caffeine and theophylline as adenosine receptor antagonists in humans.
Biaggioni, I., Paul, S., Puckett, A., & Arzubiaga, C. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20409-8 · Cited by 213
Self-citationMogul, D. J., Adams, M. E., & Fox, A. P. (1993) · Neuron · doi:10.1016/0896-6273(93)90322-i · Cited by 206
Linden, J., Taylor, H. E., Robeva, A. S., Tucker, A. L., Stehle, J. H., Rivkees, S. A., Fink, J. S., & Reppert, S. M. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13220-3 · Cited by 204
Ali, H., Cunha-Melo, J. R., Saul, W. F., & Beaven, M. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40113-0 · Cited by 190
Rafferty, P., Beasley, R. W., & Holgate, S. T. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.2.369 · Cited by 184
Hughes, P. J., Holgate, S. T., & Church, M. K. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90050-9 · Cited by 174
Seuwen, K., Lagarde, A., & Pouysségur, J. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02796.x · Cited by 138
Holgate, S. T., Lewis, R. A., & Austen, K. F. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6800 · Cited by 138
Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline.
Cushley, M. J., Tattersfield, A. E., & Holgate, S. T. (1984) · PubMed · doi:10.1164/arrd.1984.129.3.380 · Cited by 132
Expression of multiple chemokine genes by a human mast cell leukemia.
Selvan, R. S., Butterfield, J. H., & Krangel, M. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36731-5 · Cited by 129
Adenosine-induced bronchoconstriction in asthma: Role of mast cell-mediator release
Cushley, M. J., & Holgate, S. T. (1985) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(85)90057-0 · Cited by 124
Effects of enprofylline and theophylline may show the role of adenosine
Persson, C. G. A., Andersson, K., & KJELLIN, G. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90241-9 · Cited by 115
Specific antagonism of adenosine‐induced bronchoconstriction in asthma by oral theophylline.
Mann, J. S., & Holgate, S. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02696.x · Cited by 105
Marquardt, D. L., Walker, L. L., & Wasserman, S. I. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.2.932 · Cited by 71
Feoktistov, I., Murray, J. J., & Biaggioni, I. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10573-7 · Cited by 61
Self-citationA Gs protein couples P2-purinergic stimulation to cardiac Ca channels without cyclic AMP production.
Scamps, F., Rybin, V. O., Pucéat, M., Va, T., & Vassort, G. (1992) · The Journal of General Physiology · doi:10.1085/jgp.100.4.675 · Cited by 58
Church, M. K., Hughes, P., & Vardey, C. J. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb10176.x · Cited by 56
Clarke, H., Cushley, M. J., Persson, C. G. A., & Holgate, S. T. (1989) · Pulmonary Pharmacology · doi:10.1016/0952-0600(89)90039-2 · Cited by 41
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Metadata
- Authors
- Feoktistov, I., & Biaggioni, I.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-10-01
- Volume
- 96
- Issue
- 4
- Pages
- 1979-1986
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2101535048
- Cited by
- 363
- References
- 29
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.